Fourway Pharma LLP

Brand	INFANRIX HEXA VACCINE
Dose Strength	10 µg
Pack Size	0.5ML
Packaging Size	0.5ML
Composition	Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliom
Treatment	diphtheria, tetanus, pertussis (whooping cough), hepatitis B, poliomyelitis (polio), and invasive di
Country of Origin	Made in India

Infanrix hexa is a six-in-one vaccine used for the primary and booster vaccination of infants and young children against six serious diseases: diphtheria, tetanus, pertussis (whooping cough), hepatitis B, poliomyelitis (polio), and invasive diseases caused by Haemophilus influenzae type b (Hib). It works by stimulating the immune system to produce antibodies to protect against these infections, which can otherwise cause severe health issues like paralysis, respiratory problems, and organ damage. 

Additional Information:

• Production Capacity: 1000
• Delivery Time: 1 TO 2 DAYS
• Packaging Details: The vaccine is prepared by injecting the contents of the syringe into the vial, followed by shaking until the powder is completely dissolved. The reconstituted vaccine is a slightly more cloudy suspension than the liquid component alone, which is normal. The syringe is typically made of Type I glass and comes with a plunger stopper (butyl). Packs can be sold with or without needles, and are available in quantities of 1, 10, 20, and 50.

Packaging Size	0.5ML
Brand	HEXASIIL VACCINE
Composition	Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis
Treatment	active immunization of infants to protect them against six serious diseases: diphtheria, tetanus, pe
Prescription/Non prescription	Prescription
Form	Injection
Shelf life	18 MONTHS
Product Type	PRE FILLED SYRINGE
Packing Type	0.5ML
Item Name	HEXASIIL VACCINE 0.5ML

Hexasiil is a hexavalent vaccine used to actively immunize infants aged six weeks and older against six serious diseases: diphtheria, tetanus, pertussis (whooping cough), hepatitis B, poliomyelitis (polio), and invasive diseases caused by Haemophilus influenzae type b (Hib). A primary vaccination series consists of three doses given at 6, 10, and 14 weeks, followed by a booster dose between 12 and 24 months of age. 

Additional Information:

• Production Capacity: 1000
• Delivery Time: 1 TO 2 DAYS
• Packaging Details: Hexasiil vaccine is packaged in various formats, including cartons of 50 vials (500 doses) and cartons of 300 vials (3000 doses). A shipping box contains 1200 vials (12000 doses). Each dose is a single, pre-filled syringe or vial of 0.5 ml.

Indication	Hepatitis
Vaccine Type	Toxoid
Age Group	Pediatric
Dose Volume	0.5 ml
Presentation	PFS
Route	IM
Packaging Size	0.5ML
Brand	EQASY SIX VACCINE
Composition	Diphtheria Tetanus Pertussis (whooping cough) Hepatitis B Poliomyelitis (polio) Severe infections ca
Treatment	used to protect infants and toddlers from six months of age against six diseases: diphtheria, tetanu
Prescription/Non prescription	Prescription
Form	Injection
Shelf life	12 MONTHS
Pack Size	Single dose
Product Type	INJECTION
Prescription	Prescription
Packing Type	0.5ML
Item Name	EASY SIX VACCINE
Set Content	Diphtheria Tetanus Pertussis (whooping cough) Hepatitis B Poliomyelitis (polio) Severe infections ca
Manufactured By	PANACEA BIOTEC
Company Name	PANACEA BIOTEC
Country of Origin	Made in India

Easy Six is a combination vaccine that protects infants and toddlers against six diseases: diphtheria, tetanus, pertussis (whooping cough), hepatitis B, poliomyelitis (polio), and severe infections from Haemophilus influenzae type b*. It is given as a primary series of doses at around 6, 10, and 14 weeks of age, with a booster dose in the second year of life, to help build immunity to these serious illnesses. 

Additional Information:

• Production Capacity: 1000
• Delivery Time: 1 TO 2 DAYS
• Packaging Details: The Easy Six vaccine (a DTwP-HepB-Hib-IPV hexavalent combination vaccine) is available in two main types of packaging, both containing a single pediatric dose of 0.5 ml: Prefilled Syringe (PFS): A single-dose, 0.5 ml prefilled syringe made of USP Type 1 glass, supplied along with a 25G 1" needle. Vial: Available as a single-dose vial containing 0.5 ml of the vaccine, or a multi-dose vial containing 2.0 ml (4 doses).

Strength	300 mcg
Brand	immunoglobin
Dose Volume	1 ml
Indication	Transfusion
Presentation	PFS
Source	Human
Route	IM
Storage Temp	2–8°C

Anti-D 300mcg injection prevents Rh disease (hemolytic disease of the newborn) by stopping an Rh-negative person's immune system from attacking Rh-positive blood cells, crucial during pregnancy for Rh-negative mothers with Rh-positive babies, after miscarriages, or following mismatched Rh-positive blood transfusions in Rh-negative patients, protecting future pregnancies and health. 

• Pregnancy: Given to Rh-negative mothers during the third trimester and after delivery (if the baby is Rh-positive) to prevent sensitization. 
• Miscarriage/Abortion: Administered after a miscarriage or abortion to Rh-negative women to stop immune response to fetal blood. 
• Trauma/Procedures: Given after abdominal trauma, amniocentesis, or other events where fetal blood might enter the mother's system. 
• Blood Transfusions: Used for Rh-negative individuals who accidentally receive Rh-positive blood. 

Additional Information:

• Production Capacity: 10000
• Delivery Time: 1 to 2 days
• Packaging Details: Form: Liquid. Concentration: 300 mcg/1ml. Container: Prefilled Syringe (PFS). Syringe Features: USP Type-I glass, siliconized, with safety guard and lock-clip. Packaging Unit: Often sold as a single prefilled syringe (1ml). Inner Packaging: Plastic tray holding the syringe, with a pack insert. Outer Packaging: Carton box.

Packaging Size	0.5 ml
Packaging Type	PREFILLED SYRINGE
Composition	Varicella Vaccine
Manufacturer	GLAXO SMITH KLINE
Country of Origin	Made in India

Varilrix is a vaccine used to prevent chickenpox (varicella) in healthy individuals, including children from 9 months of age and adults. It may also be used for post-exposure prophylaxis if given within 72 hours of contact with the virus. The vaccine works by stimulating the immune system to produce antibodies against the varicella-zoster virus, and it is typically administered as two doses.

Additional Information:

• Production Capacity: 1000
• Delivery Time: 1 TO 2 DAYS
• Packaging Details: VARILRIX vaccine is supplied as a lyophilised powder and a separate diluent for solution and injection. It is typically available in single-dose or multi-dose (e.g., 10-pack) configurations, with the diluent provided in either a pre-filled syringe or a glass ampoule. accine Powder: The powder is a slightly cream to yellowish or pinkish-coloured cake or powder contained in a single-dose 3 mL clear glass vial with a rubber stopper. Diluent: The diluent is sterile water for injection, which is a clear and colourless liquid. It is supplied in either a clear glass ampoule or a pre-filled syringe made of Type I glass. The pre-filled syringe may or may not include one or two separate needles in the package. Outer Packaging: The primary components (vial and diluent) are contained within a cardboard carton or a "packet".